Monitoring, Dose Adjustment, and When to Pause Treatment Warning signs include persistent severe nausea, vomiting that prevents food or fluid intake, abdominal bloating unrelieved by position change, or inability to tolerate any oral intake after two weeks of stable dosing
T2D independently elevates colorectal cancer risk, though the cumulative impact of both conditions had not previously been studied at scale
The improvement in glucose tolerance observed in WD mice treated with GLP-1 or Ex4 in the OB was partly due to an increase in insulin secretion during OGTT (Fig
Thus, the cardiovascular protective effect of metformin is still inconclusive
Several GLP-1based medications are approved for chronic weight management in people without diabetes, depending on local regulatory approvals and eligibility criteria
Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from l cells and alpha cells